Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
2021
2020
2019
Profitability Metrics
Gross Margin
100.00%
Operating Margin
87.87%
Net Margin
130.56%
Efficiency Metrics
Revenue per Expense Ratio
8.24
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
0.00%
Income Tax Rate
0.00%
EPS
0.7400000000
Balance Sheet Analysis
Current Ratio
0.26
Cash Ratio
0.00
Working Capital
$-39.54M
Debt to Equity
0.18
Debt to Assets
15.10%
Equity Ratio
84.18%
Cash Flow Analysis
Operating Cash Flow Ratio
52.55%
Free Cash Flow Ratio
52.55%
CapEx to Revenue
0.00%
Dividends Paid
$26.81M
Stock Buybacks
$1.76M
Total Shareholder Returns
$28.57M
Cash Position Change
-28.76%
Key Takeaways (2023 FY)
Maintained positive net income growth despite revenue changes
Detailed Growth Metrics
Core Performance
Revenue
146.26%
Net Income
159.22%
EPS
159.68%
Operating Income
141.07%
Operational Efficiency
R&D Expenses
-100.00%
SG&A Expenses
1,422.32%
Operating Cash Flow
-58.12%
Free Cash Flow
-58.12%
Balance Sheet Health
Assets
5.92%
Debt
38.89%
Book Value per Share
3.01%
Inventory
-100.00%
Shareholder Returns
Dividends per Share
-13.52%
Shares Outstanding
-0.66%
Long Term Trends
3Y Revenue/Share
226.32%
5Y Revenue/Share
161.85%
3Y Dividend/Share
0.00%
5Y Dividend/Share
-13.36%